These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Assessment of the association between the presence of fragmented QRS and the predicted risk score of sudden cardiac death at 5 years in patients with hypertrophic cardiomyopathy. Özyılmaz S; Akgül Ö; Uyarel H; Pusuroğlu H; Karayakalı M; Gül M; Çetin M; Satılmışoğlu H; Yıldırım A; Bakır İ Anatol J Cardiol; 2017 Jul; 18(1):54-61. PubMed ID: 28559533 [TBL] [Abstract][Full Text] [Related]
12. ST-segment depression as a risk factor in hypertrophic cardiomyopathy. Haghjoo M; Mohammadzadeh S; Taherpour M; Faghfurian B; Fazelifar AF; Alizadeh A; Rad MA; Sadr-Ameli MA Europace; 2009 May; 11(5):643-9. PubMed ID: 19164362 [TBL] [Abstract][Full Text] [Related]
13. Impaired repolarization parameters may predict fatal ventricular arrhythmias in patients with hypertrophic cardiomyopathy (from the CILICIA Registry). Güner A; Kalçık M; Çelik M; Uzun F; Çizgici AY; Ağuş HZ; Aslan S; Güner EG; Ulutaş AE; Bayam E; Kalkan ME J Electrocardiol; 2020; 63():83-90. PubMed ID: 33142186 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy. Maurizi N; Olivotto I; Olde Nordkamp LR; Baldini K; Fumagalli C; Brouwer TF; Knops RE; Cecchi F Heart Rhythm; 2016 Feb; 13(2):457-63. PubMed ID: 26362577 [TBL] [Abstract][Full Text] [Related]
15. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy. Francia P; Adduci C; Palano F; Semprini L; Serdoz A; Montesanti D; Santini D; Musumeci B; Salvati A; Volpe M; Autore C J Cardiovasc Electrophysiol; 2015 Aug; 26(8):893-899. PubMed ID: 25996259 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for lethal arrhythmic events in children and adolescents with hypertrophic cardiomyopathy and an implantable defibrillator: An international multicenter study. Balaji S; DiLorenzo MP; Fish FA; Etheridge SP; Aziz PF; Russell MW; Tisma S; Pflaumer A; Sreeram N; Kubus P; Law IH; Kantoch MJ; Kertesz NJ; Strieper M; Erickson CC; Moore JP; Nakano SJ; Singh HR; Chang P; Cohen M; Fournier A; Ilina MV; Smith RT; Zimmerman F; Horndasch M; Li W; Batra A; Liberman L; Hamilton R; Janson CM; Sanatani S; Zeltser I; McDaniel G; Blaufox AD; Garnreiter JM; Katcoff H; Shah M Heart Rhythm; 2019 Oct; 16(10):1462-1467. PubMed ID: 31026510 [TBL] [Abstract][Full Text] [Related]
17. ECG-derived spatial QRS-T angle is strongly associated with hypertrophic cardiomyopathy. Cortez D; Schlegel TT; Ackerman MJ; Bos JM J Electrocardiol; 2017; 50(2):195-202. PubMed ID: 27839835 [TBL] [Abstract][Full Text] [Related]
18. Microvolt QRS Alternans Without Microvolt T-Wave Alternans in Human Cardiomyopathy: A Novel Risk Marker of Late Ventricular Arrhythmias. Suszko A; Nayyar S; Labos C; Nanthakumar K; Pinter A; Crystal E; Chauhan VS J Am Heart Assoc; 2020 Sep; 9(17):e016461. PubMed ID: 32806990 [TBL] [Abstract][Full Text] [Related]
19. ECG quantification of myocardial scar in cardiomyopathy patients with or without conduction defects: correlation with cardiac magnetic resonance and arrhythmogenesis. Strauss DG; Selvester RH; Lima JA; Arheden H; Miller JM; Gerstenblith G; Marbán E; Weiss RG; Tomaselli GF; Wagner GS; Wu KC Circ Arrhythm Electrophysiol; 2008 Dec; 1(5):327-36. PubMed ID: 19808427 [TBL] [Abstract][Full Text] [Related]
20. Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy. Shiozaki AA; Senra T; Arteaga E; Martinelli Filho M; Pita CG; Ávila LF; Parga Filho JR; Mady C; Kalil-Filho R; Bluemke DA; Rochitte CE J Cardiovasc Comput Tomogr; 2013; 7(3):173-81. PubMed ID: 23849490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]